Oligonucleotide Synthesis, Modification, and Purification Services Market worth $6.53 Billion by 2030 - Exclusive Report by InsightAce Analytic
Retrieved on:
Tuesday, July 5, 2022
GE Healthcare, Integrated DNA Technologies, Medication, Research, NGS, Hospital, COVID-19, Growth, Uridine, Diagnosis, Mass spectrometry, Vaccine, Molecular biology, Lists of diseases, Oligonucleotide, RNA transfection, Integration, CMOS, GMP, Thermo Fisher Scientific, Dharmacon, CAGR, RNA, Mirna, Contract, SNP, Biotechnology, Wuxi, LC, Viral Research and Diagnostic Laboratories, Merck Millipore, University of Sheffield, Sheffield, PCR, Degenerative disease, Nucleotide, CDMO, OEM, Bio-Synthesis, Inc., University, Biochemistry, DNA, Regulus Therapeutics, Medicine, Uridine triphosphate, Agilent Technologies, Fine chemical
Ltd. announces the release of a market assessment report on the " Global Oligonucleotide Synthesis, Modification and Purification Services Market Oligonucleotide Mfg.
Key Points:
- Ltd. announces the release of a market assessment report on the " Global Oligonucleotide Synthesis, Modification and Purification Services Market Oligonucleotide Mfg.
- According to the latest research by InsightAce Analytic, the global oligonucleotide synthesis, modification, and purification services market is valued at US$ 1.56 billion in 2021, and it is expected to reach US$ 6.53 billion by 2030 with a CAGR of 17.50% during a forecast period of 2022-30.
- Recently, there has been an augmented interest in involving modified oligoribonucleotides in molecular biology, biochemistry, and medicine.
- However, the high expenses for the purification process, complex manufacturing procedures, oligo-degradation in the generic research, in-house development of oligonucleotides may hinder the growth of the global oligonucleotide synthesis, modification, and purification services market.